Neurologically-active compounds
US6632806B1 · kind B1 · utility
0Cited by
3References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 22, 1999 |
| Grant date | Oct 14, 2003 |
| Priority date | — |
| Expiry date | Dec 22, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/59
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods for enhancing cognitive activity and stimulating memory capacity, comprising the step of administering an effective amount of a compound with GABAC receptor antagonist activity to an animal in need of such treatment. Preferably the compound has selective GABAc receptor antagonist activity, and more preferably comprises a phosphinic acid group. The invention also provides novel compounds and compositions. The methods of the invention are useful in the treatment of dementias and conditions involving cognitive deficit, or memory impairment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.